“Patients with Alzheimer’s disease have an increased removal rate of soluble beta-amyloid-42,” by Dmitry V. Zaretsky, Maria V. Zaretskaia, Yaroslav I. Molkov, for the Alzheimer’s Disease Neuroimaging Initiative (PLoS ONE 17(10): e0276933. doi.org/10.1371/journal.pone.0276933, XML, HTML, and .pdf format, 21p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0276933
